Circulating Biochemical Marker Levels of Collagen Metabolism Are Abnormal in Patients with Abdominal Aortic Aneurysm

Abstract

Changes in extracellular matrix composition induced by abnormal collagen metabolism in the aortic wall may be an important factor in the progression of aortic structural changes. The authors have measured several types of biochemical marker for collagen metabolism in plasma: carboxyterminal propeptide of type I collagen (PICP) for a pure collagen synthesis marker, matrix metalloproteinase-1 (MMP-1) for a degradation marker of collagen matrix, and tissue inhibitors of metalloproteinase-1 (TIMP-1) as a native inhibitor of MMP-1. Subjects of this study were 17 patients with abdominal aortic aneurysm (AAA), 14 patients with atherosclerosis obliterans (ASO), and 22 age/sex matched healthy controls (HC). Blood samples were drawn from a forearm vein and measured by radioimmunoassay or enzyme-linked immunosorbent assay. Plasma concen trations of PICP in patients with AAA were significantly decreased compared to those in HC patients (82.0 ±16.4 vs 111.3 ±40.3 ng/mL; p<0.01), but those in patients with ASO (105.4 ±55.4 ng/mL) were comparable to control concentrations. Although no differences in plasma concentrations of MMP-1 were observed among the three subject groups (HC, 20.0 ± 5.6 ng/mL; ASO, 21.4 ± 13.8 ng/mL; AAA, 24.5 ±11.7 ng/mL; NS), MMP-1/PICP ratio as an index of collagen degradation to collagen neosynthesis in AAA was significantly elevated compared to HC (0.32 ±0.18 vs 0.20 ±0.08; p < 0.01). Plasma concentrations of TIMP-1 in patients with AAA (293.8 ±61.2 ng/mL) or ASO (327.6 ±54.9 ng/mL) were significantly higher than in HC (227.3 ±60.2 ng/mL; both p < 0.01). In conclusion, these data suggest that although a compensatory mechanism such as increased TIMP-1 may be activated, collagen neosynthesis may decrease with relatively increased collagen degradation in patients with AAA.

Get full access to this article

View all access options for this article.

References

Irizarry E. , Newman KM , Gandhi RH , et al: Demonstration of interstitial collagenase in abdominal aortic aneurysm disease. J Surg Res 54:571-574, 1993.

Newman KM , Ogata Y. , Malon AM , et al: Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb 14:1315-1320, 1994.

Patel MI , Melrose J. , Ghosh P. , et al: Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms . J Vasc Surg 24:82-92, 1996.

Sakalihasan N. , Delvenne P. , Nusgens BV , et al: Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 24:127-133, 1996.

Knox JB , Sukhova GK , Whittemore AD , et al: Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95:205-212, 1997.

McMillan WD , Tamarina NA , Cipollone M. , et al: Size matters: The relationship between MMP-9 expression and aortic diameter. Circulation 96:2228-2232, 1997.

Curci JA , Liao S. , Huffman MD , et al: Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 102:1900-1910, 1998.

Diez J. , Laviades C. : Monitoring fibrillar collagen turnover in hypertensive heart disease. Cardiovasc Res 35:202-205, 1997.

Risteli J. , Niemi S. , Kauppila S. , et al: Collagen propeptides as indicators of collagen assembly. Acta Orthop Scand 266(suppl):183-188, 1995.

10.

Takino T. , Nakamura M. , Hiramori K. : Circulating levels of carboxyterminal propeptide of type I procollagen and left ventricular remodelling after myocardial infarction. Cardiology 91:81-86, 1999.

11.

Risteli L. , Risteli J. : Noninvasive methods of detection of organ fibrosis. In: Connective Tissue in Health and Disease, ed. by Rojkind M. Boca Raton FL: CRC Press, 1990, 1:61-98.

12.

Mesh CL , Baxter BT , Pearce WH , et al: Collagen and elastin gene expression in aortic aneurysms. Surgery 112:256-262, 1992.

13.

Rizzo RJ , McCarthy WJ , Dixit SN , et al: Collagen types and matrix protein content in human abdominal aortic aneurysms. J Vasc Surg 10:365-373, 1989.

14.

Sumner DS , Hokanson DE , Strandness DE Jr: Stress-strain characteristics and collagen-elastin content of abdominal aortic aneurysms. Surg Gynecol Obstet 130:459-466, 1970.

15.

Satta J. , Haukipuro K. , Kairaluoma MI , et al: Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms. J Vasc Surg 25:909-915, 1997.

16.

Satta J. , Juvonen T. , Haukipuro K. , et al: Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples. J Vasc Surg 22:155-160, 1995.

17.

McMillan WD , Pearce WH : Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 29:122-127, 1999.

18.

Newman KM , Malon AM , Shin RD , et al: Matrix metalloproteinases in abdominal aortic aneurysm: Characterization, purification, and their possible sources. Conn Tiss Res 30:265-276, 1994.

19.

Tamarina NA , McMillan WD , Shively VP , et al: Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 122:264-272, 1997.

20.

Webster MW , McAuley CE , Steed DL , et al: Collagen stability and collagenolytic activity in the normal and aneurysmal human abdominal aorta. Am J Surg 161:635-638, 1991.

21.

Allaire E. , Forough R. , Clowes M. , et al: Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 102:1413-1420, 1998.